Total synthesis of [13C2]-labeled phytosiderophores of the mugineic and avenic acid families

IF 0.9 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS
Nicolas Kratena, Markus Draskovits, Nina Biedermann, Eva Oburger, Christian Stanetty
{"title":"Total synthesis of [13C2]-labeled phytosiderophores of the mugineic and avenic acid families","authors":"Nicolas Kratena,&nbsp;Markus Draskovits,&nbsp;Nina Biedermann,&nbsp;Eva Oburger,&nbsp;Christian Stanetty","doi":"10.1002/jlcr.4064","DOIUrl":null,"url":null,"abstract":"<p>We, herein, report the synthesis of <sup>13</sup>C<sub>2</sub>-labeled natural products from the mugineic acid and avenic acid family. These phytosiderophores (“plant iron carriers”) are built up from non-proteinogenic amino acids and play a key role in micronutrient uptake in gramineous plants. In this work, two central building blocks are prepared from labeled starting materials (<sup>13</sup>C<sub>2</sub>-bromoacetic acid, <sup>13</sup>C<sub>2</sub>-glycine) and further employed in our recently reported divergent, branched synthetic strategy delivering eight isotopically labeled phytosiderophores. The required labeled building blocks (<sup>13</sup>C<sub>2</sub>-<span>l</span>-allylglycine and a related hydroxylated derivative) were prepared via enantioselective phase-transfer catalysis and enantio- and diastereoselective aldol condensation with a chiral auxiliary, respectively, both potentially valuable themselves for other synthetic routes toward labeled (natural) products.</p>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":"66 13","pages":"428-434"},"PeriodicalIF":0.9000,"publicationDate":"2023-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/epdf/10.1002/jlcr.4064","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of labelled compounds & radiopharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jlcr.4064","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

We, herein, report the synthesis of 13C2-labeled natural products from the mugineic acid and avenic acid family. These phytosiderophores (“plant iron carriers”) are built up from non-proteinogenic amino acids and play a key role in micronutrient uptake in gramineous plants. In this work, two central building blocks are prepared from labeled starting materials (13C2-bromoacetic acid, 13C2-glycine) and further employed in our recently reported divergent, branched synthetic strategy delivering eight isotopically labeled phytosiderophores. The required labeled building blocks (13C2-l-allylglycine and a related hydroxylated derivative) were prepared via enantioselective phase-transfer catalysis and enantio- and diastereoselective aldol condensation with a chiral auxiliary, respectively, both potentially valuable themselves for other synthetic routes toward labeled (natural) products.

Abstract Image

木霉酸和燕麦酸家族[13C2]-标记的植物铁载体的全合成。
在此,我们报道了13个C2标记的天然产物的合成,这些产物来自木甘酸和燕麦酸家族。这些植物铁载体(“植物铁载体”)由非蛋白质氨基酸组成,在禾本科植物吸收微量营养素方面发挥着关键作用。在这项工作中,由标记的起始材料(13C2-溴乙酸,13C2-甘氨酸)制备了两个中心构建块,并进一步用于我们最近报道的提供八种同位素标记的植物铁载体的发散、分支合成策略。所需的标记构建块(13C2-l-烯丙基甘氨酸和相关的羟基化衍生物)分别通过对映选择性相转移催化和与手性助剂的对映和非对映选择性羟醛缩合制备,这两种方法本身都有潜在的价值,可用于标记(天然)产物的其他合成途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.30
自引率
0.00%
发文量
57
审稿时长
1 months
期刊介绍: The Journal of Labelled Compounds and Radiopharmaceuticals publishes all aspects of research dealing with labeled compound preparation and applications of these compounds. This includes tracer methods used in medical, pharmacological, biological, biochemical and chemical research in vitro and in vivo. The Journal of Labelled Compounds and Radiopharmaceuticals devotes particular attention to biomedical research, diagnostic and therapeutic applications of radiopharmaceuticals, covering all stages of development from basic metabolic research and technological development to preclinical and clinical studies based on physically and chemically well characterized molecular structures, coordination compounds and nano-particles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信